Evidence map›Paper›PMID 25480792›Full record

ArticleThe Journal of biological chemistry2015

The β-lactamase gene regulator AmpR is a tetramer that recognizes and binds the D-Ala-D-Ala motif of its repressor UDP-N-acetylmuramic acid (MurNAc)-pentapeptide.

Grishma Vadlamani, Misty D Thomas, Trushar R Patel, Lynda J Donald, Thomas M Reeve, Jörg Stetefeld, Kenneth G Standing, David J Vocadlo, Brian L Mark

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed.

  1. Review
  2. From Environmental Organism to Nosocomial Threat:Antibiotics (Basel, Switzerland) · 2026
    Review
  3. Article
  4. Review
  5. A novel mechanism of ceftolozane-tazobactam resistance inbioRxiv : the preprint server for biology · 2026
    Article
  6. TheInternational journal of molecular sciences · 2026
    Review
  7. Antibiotic resistance inFrontiers in microbiology · 2026
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. The L-lactate dehydrogenases ofbioRxiv : the preprint server for biology · 2024
    Article
  17. Review
  18. Article
  19. PeerJ · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Grishma VadlamaniFrom the Departments of Microbiology.
Misty D ThomasFrom the Departments of Microbiology.
Trushar R PatelChemistry, and.
Lynda J DonaldChemistry, and.
Thomas M ReeveFrom the Departments of Microbiology.
Jörg StetefeldChemistry, and.
Kenneth G StandingPhysics and Astronomy, University of Manitoba, Winnipeg, Manitoba R3T 2N2, Canada and.
David J Vocadlothe Department of Chemistry, Simon Fraser University, Burnaby, British Columbia V5A 1S6, Canada.
Brian L MarkFrom the Departments of Microbiology, brian.mark@umanitoba.ca.

Funding

Canadian Institutes of Health Research MOP-97818
6 · The paper itself

Abstract

Inducible expression of chromosomal AmpC β-lactamase is a major cause of β-lactam antibiotic resistance in the Gram-negative bacteria Pseudomonas aeruginosa and Enterobacteriaceae. AmpC expression is induced by the LysR-type transcriptional regulator (LTTR) AmpR, which activates ampC expression in response to changes in peptidoglycan (PG) metabolite levels that occur during exposure to β-lactams. Under normal conditions, AmpR represses ampC transcription by binding the PG precursor UDP-N-acetylmuramic acid (MurNAc)-pentapeptide. When exposed to β-lactams, however, PG catabolites (1,6-anhydroMurNAc-peptides) accumulate in the cytosol, which have been proposed to competitively displace UDP-MurNAc-pentapeptide from AmpR and convert it into an activator of ampC transcription. Here we describe the molecular interactions between AmpR (from Citrobacter freundii), its DNA operator, and repressor UDP-MurNAc-pentapeptide. Non-denaturing mass spectrometry revealed AmpR to be a homotetramer that is stabilized by DNA containing the T-N11-A LTTR binding motif and revealed that it can bind four repressor molecules in an apparently stepwise manner. A crystal structure of the AmpR effector-binding domain bound to UDP-MurNAc-pentapeptide revealed that the terminal D-Ala-D-Ala motif of the repressor forms the primary contacts with the protein. This observation suggests that 1,6-anhydroMurNAc-pentapeptide may convert AmpR into an activator of ampC transcription more effectively than 1,6-anhydroMurNAc-tripeptide (which lacks the D-Ala-D-Ala motif). Finally, small angle x-ray scattering demonstrates that the AmpR·DNA complex adopts a flat conformation similar to the LTTR protein AphB and undergoes only a slight conformational change when binding UDP-MurNAc-pentapeptide. Modeling the AmpR·DNA tetramer bound to UDP-MurNAc-pentapeptide predicts that the UDP-MurNAc moiety of the repressor participates in modulating AmpR function.

Indexed as

Bacterial Proteinsbeta-LactamasesDipeptidesPeptidoglycanProtein BindingScattering, Small AngleUridine Diphosphate N-Acetylmuramic AcidalanylalanineAmpC beta-lactamasesAmpR protein, BacteriaBacterial Proteinsbeta-LactamasesDipeptidesPeptidoglycanUDP-N-acetylmuramic acid pentapeptideUridine Diphosphate N-Acetylmuramic AcidAmpC beta-LactamaseAmpRCrystal StructureLysR-type Transcriptional RegulatorMass Spectrometry (MS)PeptidoglycanSmall Angle X-ray Scattering (SAXS)Transcription

Identifiers

PMID25480792
PMCPMC4316999

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.